Program Schedule

Opportunistic Mold Infections 2014: Progress & Challenges (Not Official IDWeek Programming - Supported by Astellas, Merck, IMMY, MiraVista Diagnostics & MiraBella Technologies, T2 Biosystems, Inc, Viracor-IBT Laboratories - See Affiliated Event Guide)

Wednesday, October 8, 2014: 9:00 AM-11:00 AM
Room: The Pennsylvania Convention Center: 118-ABC

Learning Objectives:

All Satellite Symposia, Presentation Theaters, and Learning Lounges preceding and following the Official Program IDWeekTM 2014 are independently organized and executed. IDWeek does not endorse or support the programming of any Symposium, Presentation Theater or Learning Lounge.


Dimitrios P. Kontoyiannis, MD, ScD, FACP, FIDSA

Frances King Black Endowed Professor, Infectious Diseases

Deputy Head, Division of Internal Medicine 

The University of Texas MD Anderson Cancer Center

Adj Professor Baylor College of Medicine

Adj Professor University of Houston

Houston, Texas


Kieren Marr, MD

Professor of Medicine and Oncology

Director, Transplant and Oncology Infectious Diseases Program

Johns Hopkins University School of Medicine

Baltimore, Maryland


Peter Pappas, MD (Moderator)

William E. Dismukes Professor of Medicine

Principal Investigator, Mycoses Study Group

Division of Infectious Diseases

University of Alabama at Birmingham

Birmingham, Alabama


George Thompson, MD

Associate Professor of Clinical Medicine

Department of Medical Microbiology and Immunology

Department of Medicine, Division of Infectious Diseases

UC Davis Medical Center, Sacramento California

Program Overview:

Invasive mold infections have been identified with increased morbidity and mortality rates among hospitalized patients. Invasive fungal infections (IFIs) have also been associated with higher mortality rates. Delayed diagnosis and initiation of appropriate therapy may be a cause of these negative outcomes. This program will review the epidemiology, current and emerging diagnostic techniques, why therapy fails, current therapeutic options, and the development of novel treatment choices for improving care in patients with invasive mold infections and IFIs.

Breakfast will be served from 8:30 – 9 a.m.

Accreditation Statement— CME/CE Credit provided by AKH Inc., Advancing Knowledge in Healthcare.  This activity has been approved for AMA PRA Category 1 Credit™.  This activity is eligible for ACPE, ANCC, and AANP credit; see final CE activity announcement for specific details.  Full accreditation information available

Agenda subject to change and was provided by:

AKH Inc., Advancing Knowledge in Healthcare; PO Box 24104; Jacksonville, FL. 32241-4104; Phone: (904) 524-9931

Fax: (866) 352-6285; E-mail:

Please contact Trish Brignoni directly at

Target Audience: Infectious diseases physicians

CME Credits:

ACPE Credits:

ACPE Number:

See more of: Satellite Symposium

Findings in the abstracts are embargoed until 12:01 a.m. EDT, Oct. 8th with the exception of research findings presented at the IDWeek press conferences.

Sponsoring Societies:

© 2014, All Rights Reserved.

Follow IDWeek